{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:01:37Z","timestamp":1789884097873,"version":"4.0.1"},"reference-count":113,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1111\/bjd.14500","type":"journal-article","created":{"date-parts":[[2016,2,27]],"date-time":"2016-02-27T09:25:54Z","timestamp":1456565154000},"page":"250-262","source":"Crossref","is-referenced-by-count":43,"title":["Efficacy, effectiveness and safety of fumaric acid esters in the treatment of psoriasis: a systematic review of randomized and observational studies"],"prefix":"10.1093","volume":"175","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0755-3770","authenticated-orcid":false,"given":"D.M.W.","family":"Balak","sequence":"first","affiliation":[{"name":"Department of Dermatology; Erasmus MC; University Medical Center; Rotterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Fallah Arani","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Erasmus MC; University Medical Center; Rotterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Hajdarbegovic","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Erasmus MC; University Medical Center; Rotterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.A.F.","family":"Hagemans","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Erasmus MC; University Medical Center; Rotterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.M.","family":"Bramer","sequence":"additional","affiliation":[{"name":"Medical Library; Erasmus MC; University Medical Center; Rotterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.B.","family":"Thio","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Erasmus MC; University Medical Center; Rotterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.A.M.","family":"Neumann","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Erasmus MC; University Medical Center; Rotterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,7,19]]},"reference":[{"key":"10.1111\/bjd.14500-BIB0001|bjd14500-cit-0001","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.molmed.2004.11.003","article-title":"Dimethylfumarate for psoriasis: more than a dietary curiosity","volume":"11","author":"Mrowietz","year":"2005","journal-title":"Trends Mol Med"},{"issue":"Suppl. 2","key":"10.1111\/bjd.14500-BIB0002|bjd14500-cit-0002","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/j.1610-0387.2009.07059.x","article-title":"15 years of fumaderm: fumaric acid esters for the systemic treatment of moderately severe and severe psoriasis vulgaris","volume":"7","author":"Mrowietz","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/bjd.14500-BIB0003|bjd14500-cit-0003","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/jdv.12205","article-title":"Treatment of psoriasis with non-registered fumaric acid esters in The Netherlands: a nationwide survey among Dutch dermatologists","volume":"28","author":"Fallah Arani","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.14500-BIB0004|bjd14500-cit-0004","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2133.2009.09624.x","article-title":"Fumaric acid esters in the treatment of psoriasis","volume":"162","author":"Anstey","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14500-BIB0005|bjd14500-cit-0005","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/bjd.13908","article-title":"Demographics and disease characteristics of patients with psoriasis enrolled in the British Association of Dermatologists Biologic Interventions Register","volume":"173","author":"Iskandar","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14500-BIB0006|bjd14500-cit-0006","first-page":"103","article-title":"Treatment of psoriasis vulgaris","volume":"13","author":"Schweckendiek","year":"1959","journal-title":"Med Monatsschr"},{"key":"10.1111\/bjd.14500-BIB0007|bjd14500-cit-0007","first-page":"219","article-title":"Behandlung von Psoriasis mit lipoidloslichen fumarsaureverbindungen","volume":"15","author":"Schweckendiek","year":"1966","journal-title":"Medizin Heute"},{"key":"10.1111\/bjd.14500-BIB0008|bjd14500-cit-0008","first-page":"1034","article-title":"Dem Problem Psoriasis auf der Spur","volume":"18","author":"Sch\u00e4fer","year":"1971","journal-title":"Arztl Prax"},{"key":"10.1111\/bjd.14500-BIB0009|bjd14500-cit-0009","first-page":"24","article-title":"Psoriasis behandeling","volume":"7","author":"Kunst","year":"1985","journal-title":"Ned Tijdschr Geneesknd"},{"key":"10.1111\/bjd.14500-BIB0010|bjd14500-cit-0010","first-page":"1260","article-title":"Fumarsaure lindert die schuppenflechte","volume":"15","author":"Schafer","year":"1984","journal-title":"Selecta"},{"key":"10.1111\/bjd.14500-BIB0011|bjd14500-cit-0011","first-page":"1697","article-title":"Is a therapy of psoriasis through intermediate metabolism possible?","volume":"34","author":"Vonkennel","year":"1961","journal-title":"Med Welt"},{"key":"10.1111\/bjd.14500-BIB0012|bjd14500-cit-0012","first-page":"545","article-title":"Experimental treatment with fumaric acid monoethylester in psoriasis vulgaris","volume":"47","author":"Dubiel","year":"1972","journal-title":"Z Haut Geschlechtskr"},{"key":"10.1111\/bjd.14500-BIB0013|bjd14500-cit-0013","first-page":"2623","article-title":"Acute renal failure in patients treated for psoriasis with fumaric acid esters","volume":"133","author":"Roodnat","year":"1989","journal-title":"Ned Tijdschr Geneesknd"},{"key":"10.1111\/bjd.14500-BIB0014|bjd14500-cit-0014","first-page":"671","article-title":"Psoriasis therapy with fumaric acid and fumaric acid esters","volume":"59","author":"Raab","year":"1984","journal-title":"Z Hautkr"},{"key":"10.1111\/bjd.14500-BIB0015|bjd14500-cit-0015","first-page":"485","article-title":"Fumaric acid in the treatment of patients with psoriasis","volume":"129","author":"Dijk","year":"1985","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1111\/bjd.14500-BIB0016|bjd14500-cit-0016","first-page":"279","article-title":"Peroral long-term treatment of psoriasis using fumaric acid derivatives","volume":"38","author":"Bayard","year":"1987","journal-title":"Hautarzt"},{"key":"10.1111\/bjd.14500-BIB0017|bjd14500-cit-0017","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0190-9622(89)70071-2","article-title":"Systemic therapy with fumaric acid derivates: new possibilities in the treatment of psoriasis","volume":"20","author":"Nieboer","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.14500-BIB0018|bjd14500-cit-0018","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000247856","article-title":"Fumaric acid therapy in psoriasis: a double-blind comparison between fumaric acid compound therapy and monotherapy with dimethylfumaric acid ester","volume":"181","author":"Nieboer","year":"1990","journal-title":"Dermatologica"},{"key":"10.1111\/bjd.14500-BIB0019|bjd14500-cit-0019","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0190-9622(94)70121-0","article-title":"Antipsoriatic effect of fumaric acid derivatives. Results of a multicenter double-blind study in 100 patients","volume":"30","author":"Altmeyer","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.14500-BIB0020|bjd14500-cit-0020","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.clindermatol.2008.07.001","article-title":"Fumaric acid esters","volume":"26","author":"Rostami Yazdi","year":"2008","journal-title":"Clin Dermatol"},{"key":"10.1111\/bjd.14500-BIB0021|bjd14500-cit-0021","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1084\/jem.20100977","article-title":"Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells","volume":"208","author":"Ghoreschi","year":"2011","journal-title":"J Exp Med"},{"key":"10.1111\/bjd.14500-BIB0022|bjd14500-cit-0022","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/bjd.13128","article-title":"Regulated genes in psoriatic skin during treatment with fumaric acid esters","volume":"171","author":"Onderdijk","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14500-BIB0023|bjd14500-cit-0023","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1124\/jpet.114.218818","article-title":"The antipsoriatic agent monomethylfumarate has antiproliferative, prodifferentiative, and anti-inflammatory effects on keratinocytes","volume":"352","author":"Helwa","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/bjd.14500-BIB0024|bjd14500-cit-0024","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/jid.2010.416","article-title":"Dimethylfumarate inhibits angiogenesis in vitro and in vivo: a possible role for its antipsoriatic effect?","volume":"131","author":"Garcia-Caballero","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.14500-BIB0025|bjd14500-cit-0025","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2210-4-22","article-title":"In vitro pharmacokinetics of anti-psoriatic fumaric acid esters","volume":"4","author":"Litjens","year":"2004","journal-title":"BMC Pharmacol"},{"key":"10.1111\/bjd.14500-BIB0026|bjd14500-cit-0026","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00403-010-1061-4","article-title":"Pharmacokinetics of anti-psoriatic fumaric acid esters in psoriasis patients","volume":"302","author":"Rostami-Yazdi","year":"2010","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/bjd.14500-BIB0027|bjd14500-cit-0027","first-page":"48","article-title":"German psoriasis registry PsoBest: objectives, methodology and baseline data","volume":"12","author":"Augustin","year":"2014","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/bjd.14500-BIB0028|bjd14500-cit-0028","doi-asserted-by":"crossref","first-page":"g4026","DOI":"10.1136\/bmj.g4026","article-title":"Newer agents for psoriasis in adults","volume":"349","author":"Jabbar-Lopez","year":"2014","journal-title":"BMJ"},{"issue":"Suppl. 2","key":"10.1111\/bjd.14500-BIB0029|bjd14500-cit-0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-3083.2009.03389.x","article-title":"European S3-guidelines on the systemic treatment of psoriasis vulgaris","volume":"23","author":"Pathirana","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.14500-BIB0030|bjd14500-cit-0030","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1111\/jdv.13354","article-title":"European S3-Guidelines on the systemic treatment of psoriasis vulgaris - update 2015 - short version - EDF in cooperation with EADV and IPC","volume":"29","author":"Nast","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.14500-BIB0031|bjd14500-cit-0031","unstructured":"Higgins JPT Green S Cochrane handbook for systematic reviews of interventions version 5.1.0 2011 http:\/\/handbook.cochrane.org\/"},{"key":"10.1111\/bjd.14500-BIB0032|bjd14500-cit-0032","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jclinepi.2012.09.016","article-title":"Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity","volume":"66","author":"Kim","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"10.1111\/bjd.14500-BIB0033|bjd14500-cit-0033","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1111\/bjd.14500-BIB0034|bjd14500-cit-0034","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1111\/bjd.14500-BIB0035|bjd14500-cit-0035","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0190-9622(08)80766-9","article-title":"Fumaric acid therapy for psoriasis: a randomized, double-blind, placebo-controlled study","volume":"22","author":"Nugteren-Huying","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.14500-BIB0036|bjd14500-cit-0036","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1365-2133.2010.10195.x","article-title":"Fumarates vs. methotrexate in moderate to severe chronic plaque psoriasis: a multicentre prospective randomized controlled clinical trial","volume":"164","author":"Fallah Arani","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14500-BIB0037|bjd14500-cit-0037","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000063148","article-title":"Topical calcipotriol plus oral fumaric acid is more effective and faster acting than oral fumaric acid monotherapy in the treatment of severe chronic plaque psoriasis vulgaris","volume":"205","author":"Gollnick","year":"2002","journal-title":"Dermatology"},{"key":"10.1111\/bjd.14500-BIB0038|bjd14500-cit-0038","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/bjd.13277","article-title":"Addition of an oral histamine antagonist to reduce adverse events associated with fumaric acid esters in the treatment of psoriasis: a randomized double-blind placebo-controlled trial","volume":"172","author":"Balak","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14500-BIB0039|bjd14500-cit-0039","first-page":"2387","article-title":"Fumaric acid therapy in psoriasis; a double-blind, placebo-controlled study","volume":"134","author":"Nugteren-Huying","year":"1990","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1111\/bjd.14500-BIB0040|bjd14500-cit-0040","first-page":"2428","article-title":"Favourable effect of fumaric acid treatment in psoriatic arthritis: a double-blind placebo-controlled study","volume":"136","author":"Peeters","year":"1992","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1111\/bjd.14500-BIB0041|bjd14500-cit-0041","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/rheumatology\/31.7.502","article-title":"Fumaric acid therapy for psoriatic arthritis. A randomized, double-blind, placebo-controlled study","volume":"31","author":"Peeters","year":"1992","journal-title":"Br J Rheumatol"},{"key":"10.1111\/bjd.14500-BIB0042|bjd14500-cit-0042","first-page":"603","article-title":"Efficacy and safety of fumaric acid esters in the long-term treatment of psoriasis-a retrospective study (FUTURE)","volume":"7","author":"Reich","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/bjd.14500-BIB0043|bjd14500-cit-0043","first-page":"429","article-title":"Efficacy and safety of fumaric acid esters in patients with psoriasis on medication for comorbid conditions - a retrospective evaluation (FACTS)","volume":"11","author":"Tha\u00e7i","year":"2013","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/bjd.14500-BIB0044|bjd14500-cit-0044","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/bjd.12231","article-title":"Effectiveness and safety of fumaric acid esters in children with psoriasis: a retrospective analysis of 14 patients from the Netherlands","volume":"168","author":"Balak","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14500-BIB0045|bjd14500-cit-0045","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000363103","article-title":"Systemic treatment with fumaric acid esters in six paediatric patients with psoriasis in a psoriasis centre","volume":"229","author":"Steinz","year":"2014","journal-title":"Dermatology"},{"key":"10.1111\/bjd.14500-BIB0046|bjd14500-cit-0046","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/bjd.12849","article-title":"Drug survival of fumaric acid esters for psoriasis: a retrospective study","volume":"171","author":"Ismail","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14500-BIB0047|bjd14500-cit-0047","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2133.2009.09267.x","article-title":"Treatment of severe, recalcitrant, chronic plaque psoriasis with fumaric acid esters: a prospective study","volume":"162","author":"Wain","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14500-BIB0048|bjd14500-cit-0048","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/bjd.13098","article-title":"Fumaderm\u00ae in daily practice for psoriasis: dosing, efficacy and quality of life","volume":"171","author":"Walker","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14500-BIB0049|bjd14500-cit-0049","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00403-015-1541-7","article-title":"Impact of fumaric acid esters on cardiovascular risk factors and depression in psoriasis: a prospective pilot study","volume":"307","author":"Schmieder","year":"2015","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/bjd.14500-BIB0050|bjd14500-cit-0050","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.0007-0963.2004.05739.x","article-title":"Fumaric acid esters in severe psoriasis, including experience of use in combination with other systemic modalities","volume":"150","author":"Balasubramaniam","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14500-BIB0051|bjd14500-cit-0051","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000367890","article-title":"Systemic antipsoriatic combination therapy with fumaric acid esters for plaque-type psoriasis: report on 17 cases","volume":"230","author":"Wilsmann-Theis","year":"2015","journal-title":"Dermatology"},{"key":"10.1111\/bjd.14500-BIB0052|bjd14500-cit-0052","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1468-3083.2012.04596.x","article-title":"Methotrexate vs. fumaric acid esters in moderate-to-severe chronic plaque psoriasis: data registry report on the efficacy under daily life conditions","volume":"27","author":"Inzinger","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.14500-BIB0053|bjd14500-cit-0053","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1046\/j.1365-2133.2003.05433.x","article-title":"Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis","volume":"149","author":"Hoefnagel","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14500-BIB0054|bjd14500-cit-0054","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1684\/ejd.2013.2014","article-title":"Immunological changes in psoriasis patients under long-term treatment with fumaric acid esters: risk of Kaposi sarcoma occurrence?","volume":"23","author":"Philipp","year":"2013","journal-title":"Eur J Dermatol"},{"key":"10.1111\/bjd.14500-BIB0055|bjd14500-cit-0055","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1752-699X.2009.00180.x","article-title":"Organising pneumonia associated with fumaric acid ester treatment for psoriasis","volume":"4","author":"Deegan","year":"2010","journal-title":"Clin Respir J"},{"key":"10.1111\/bjd.14500-BIB0056|bjd14500-cit-0056","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2230.2006.02340.x","article-title":"Does prior treatment with fumaric acid esters predispose to tuberculosis in patients on etanercept?","volume":"32","author":"Ahmad","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.14500-BIB0057|bjd14500-cit-0057","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/j.1468-3083.2009.03234.x","article-title":"Squamous cell carcinoma as a complication of fumaric acid ester immunosuppression","volume":"23","author":"Jennings","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.14500-BIB0058|bjd14500-cit-0058","first-page":"223","article-title":"Malignant melanoma during treatment with fumaric acid esters - coincidence or treatment-related?","volume":"9","author":"Barth","year":"2011","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/bjd.14500-BIB0059|bjd14500-cit-0059","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1056\/NEJMc1211805","article-title":"PML in a patient treated with fumaric acid","volume":"368","author":"Ermis","year":"2013","journal-title":"New Engl J Med"},{"key":"10.1111\/bjd.14500-BIB0060|bjd14500-cit-0060","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1056\/NEJMc1215357","article-title":"PML in a patient treated with dimethyl fumarate from a compounding pharmacy","volume":"368","author":"Oosten","year":"2013","journal-title":"New Engl J Med"},{"key":"10.1111\/bjd.14500-BIB0061|bjd14500-cit-0061","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00415-014-7311-1","article-title":"Cerebellar manifestation of PML under fumarate and after efalizumab treatment of psoriasis","volume":"261","author":"Stoppe","year":"2014","journal-title":"J Neurol"},{"key":"10.1111\/bjd.14500-BIB0062|bjd14500-cit-0062","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/ana.24471","article-title":"Progressive neurologic dysfunction in a psoriasis patient treated with dimethyl fumarate","volume":"78","author":"Bartsch","year":"2015","journal-title":"Ann Neurol"},{"key":"10.1111\/bjd.14500-BIB0063|bjd14500-cit-0063","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12883-015-0363-8","article-title":"Case report of a patient with progressive multifocal leukoencephalopathy under treatment with dimethyl fumarate","volume":"15","author":"Dammeier","year":"2015","journal-title":"BMC Neurol"},{"key":"10.1111\/bjd.14500-BIB0064|bjd14500-cit-0064","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1212\/NXI.0000000000000085","article-title":"Progressive multifocal leukoencephalopathy during fumarate monotherapy of psoriasis","volume":"2","author":"Hoepner","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1111\/bjd.14500-BIB0065|bjd14500-cit-0065","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1056\/NEJMc1413724","article-title":"PML in a patient without severe lymphocytopenia receiving dimethyl fumarate","volume":"372","author":"Nieuwkamp","year":"2015","journal-title":"New Engl J Med"},{"key":"10.1111\/bjd.14500-BIB0066|bjd14500-cit-0066","first-page":"554","article-title":"Osteomalacia as an apparently rare side effect of oral fumaric acid therapy. Secondary DeToni-Debr\u00e9 Fanconi syndrome in the adult","volume":"43","author":"Fliegner","year":"1992","journal-title":"Hautarzt"},{"key":"10.1111\/bjd.14500-BIB0067|bjd14500-cit-0067","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2165\/00044011-199917040-00010","article-title":"Fumaric acid ester-induced diffuse renal tubular injury presenting as Fanconi syndrome and osteomalacia","volume":"17","author":"Haviv","year":"1999","journal-title":"Clin Drug Invest"},{"key":"10.1111\/bjd.14500-BIB0068|bjd14500-cit-0068","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1191\/096032799678839662","article-title":"Longterm treatment of psoriasis using fumaric acid preparations can be associated with severe proximal tubular damage","volume":"18","author":"Raschka","year":"1999","journal-title":"Hum Exp Toxicol"},{"key":"10.1111\/bjd.14500-BIB0069|bjd14500-cit-0069","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1055\/s-2008-1043567","article-title":"Adult Debre-de Toni-Fanconi syndrome with osteomalacia, acquired through long-term psoriasis therapy with fumaric acid ester - and a contribution to malacic osteoarthropathy","volume":"24","author":"Schilling","year":"1999","journal-title":"Akt Rheumatol"},{"key":"10.1111\/bjd.14500-BIB0070|bjd14500-cit-0070","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s001130050756","article-title":"Multiple pathological fractures in acquired Fanconi's syndrome after treatment of psoriasis with fumaric acid","volume":"104","author":"Warzecha","year":"2001","journal-title":"Unfallchirurg"},{"issue":"Suppl. 1","key":"10.1111\/bjd.14500-BIB0071|bjd14500-cit-0071","first-page":"P10","article-title":"de Toni-Fanconi syndrome secondary to fumaric acid esters","volume":"169","author":"Reid","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14500-BIB0072|bjd14500-cit-0072","first-page":"1138","article-title":"Collagenous colitis during treatment with fumaric acid esters","volume":"12","author":"Hoffmann","year":"2014","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/bjd.14500-BIB0073|bjd14500-cit-0073","doi-asserted-by":"crossref","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"key":"10.1111\/bjd.14500-BIB0074|bjd14500-cit-0074","first-page":"CD010497","article-title":"Oral fumaric acid esters for psoriasis","volume":"8","author":"Atwan","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/bjd.14500-BIB0075|bjd14500-cit-0075","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2133.2008.08732.x","article-title":"Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials","volume":"159","author":"Schmitt","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14500-BIB0076|bjd14500-cit-0076","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/bjd.12663","article-title":"Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials","volume":"170","author":"Schmitt","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14500-BIB0077|bjd14500-cit-0077","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta4400","article-title":"A systematic review of treatments for severe psoriasis","volume":"4","author":"Griffiths","year":"2000","journal-title":"Health Technol Assess"},{"key":"10.1111\/bjd.14500-BIB0078|bjd14500-cit-0078","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/j.1523-1747.2003.12605.x","article-title":"Dimethylfumarate is a potent inducer of apoptosis in human T cells","volume":"121","author":"Treumer","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.14500-BIB0079|bjd14500-cit-0079","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/sj.jid.5700686","article-title":"Dimethylfumarate induces immunosuppression via glutathione depletion and subsequent induction of heme oxygenase 1","volume":"127","author":"Lehmann","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.14500-BIB0080|bjd14500-cit-0080","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0190-9622(08)80228-9","article-title":"Fumaric acid therapy in psoriasis: results and side effects of 2 years of treatment","volume":"27","author":"Kolbach","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.14500-BIB0081|bjd14500-cit-0081","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2165\/00126839-200506040-00005","article-title":"BG 12: BG 00012, BG 12\/Oral Fumarate, FAG-201, second-generation fumarate derivative-Fumapharm\/Biogen Idec","volume":"6","author":"Anonymous","year":"2005","journal-title":"Drugs R D"},{"key":"10.1111\/bjd.14500-BIB0082|bjd14500-cit-0082","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa1114287","article-title":"Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis","volume":"367","author":"Gold","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.14500-BIB0083|bjd14500-cit-0083","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1056\/NEJMoa1206328","article-title":"Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis","volume":"367","author":"Fox","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.14500-BIB0084|bjd14500-cit-0084","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2133.2005.06563.x","article-title":"Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks","volume":"152","author":"Naldi","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14500-BIB0085|bjd14500-cit-0085","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1056\/NEJMc1307680","article-title":"Case reports of PML in patients treated for psoriasis","volume":"369","author":"Mrowietz","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.14500-BIB0086|bjd14500-cit-0086","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00403-012-1214-8","article-title":"German S3-guidelines on the treatment of psoriasis vulgaris (short version)","volume":"304","author":"Nast","year":"2012","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/bjd.14500-BIB0087|bjd14500-cit-0087","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/ced.12062","article-title":"Systemic methotrexate therapy for psoriasis: past, present and future","volume":"38","author":"Dogra","year":"2013","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.14500-BIB0088|bjd14500-cit-0088","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/09546634.2015.1050980","article-title":"Long-term safety and effectiveness of high-dose dimethylfumarate in the treatment of moderate to severe psoriasis: a prospective single-blinded follow-up study","volume":"27","author":"Lijnen","year":"2015","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/bjd.14500-BIB0089|bjd14500-cit-0089","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2230.2007.02389.x","article-title":"Fumaric acid esters in the management of severe psoriasis","volume":"32","author":"Brewer","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.14500-BIB0090|bjd14500-cit-0090","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/09546630310019346","article-title":"Fumaric acid esters in the treatment of psoriasis: an Italian experience","volume":"15","author":"Carboni","year":"2004","journal-title":"J Dermatol Treat"},{"key":"10.1111\/bjd.14500-BIB0091|bjd14500-cit-0091","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1046\/j.1365-2133.2003.05153.x","article-title":"Beneficial effects of fumarate therapy in psoriasis vulgaris patients coincide with downregulation of type 1 cytokines","volume":"148","author":"Litjens","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14500-BIB0092|bjd14500-cit-0092","first-page":"145","article-title":"Nephrotoxic effects of fumaric acid therapy of psoriasis","volume":"27","author":"Boesken","year":"1998","journal-title":"Nieren- Hochdruckkr"},{"key":"10.1111\/bjd.14500-BIB0093|bjd14500-cit-0093","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0926-9959(94)00056-6","article-title":"Long-term systemic therapy with dimethylfumarate and monoethylfumarate (Fumaderm) in psoriasis","volume":"4","author":"Thio","year":"1995","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.14500-BIB0094|bjd14500-cit-0094","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/jdv.12137","article-title":"Glutathione-S-transferase T1 genotyping and phenotyping in psoriasis patients receiving treatment with oral fumaric acid esters","volume":"28","author":"Gambichler","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.14500-BIB0095|bjd14500-cit-0095","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1365-2230.2012.04351.x","article-title":"Fumaric acid esters as a suitable first-line treatment for severe psoriasis: an Irish experience","volume":"37","author":"Heelan","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.14500-BIB0096|bjd14500-cit-0096","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00403-012-1227-3","article-title":"Serum levels of antimicrobial peptides and proteins do not correlate with psoriasis severity and are increased after treatment with fumaric acid esters","volume":"304","author":"Gambichler","year":"2012","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/bjd.14500-BIB0097|bjd14500-cit-0097","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2340\/00015555-1266","article-title":"Monitoring peripheral blood CD4+ intracellular adenosine triphosphate concentration in patients with psoriasis treated with fumaric acid esters","volume":"92","author":"Gambichler","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/bjd.14500-BIB0098|bjd14500-cit-0098","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00403-010-1108-6","article-title":"Systemic therapy of plaque-type psoriasis ameliorates endothelial cell function: results of a prospective longitudinal pilot trial","volume":"303","author":"Boehncke","year":"2011","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/bjd.14500-BIB0099|bjd14500-cit-0099","first-page":"648","article-title":"Early detection of renal damage caused by fumaric acid ester therapy by determination of urinary \u03b22-microglobulin","volume":"164","author":"Haring","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14500-BIB0100|bjd14500-cit-0100","first-page":"170","article-title":"Fumaric acid and its derivatives in the treatment of psoriasis vulgaris: our experience in forty-one patients","volume":"17","author":"Kokelj","year":"2009","journal-title":"Acta Dermatovenerol Croat"},{"key":"10.1111\/bjd.14500-BIB0101|bjd14500-cit-0101","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1365-2133.2006.07435.x","article-title":"Fumaric acid esters for severe psoriasis: the Leicestershire experience","volume":"155","author":"Sladden","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14500-BIB0102|bjd14500-cit-0102","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2133.2005.07103.x","article-title":"Fumaric acid esters in psoriasis","volume":"154","author":"Fika","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14500-BIB0103|bjd14500-cit-0103","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2133.2005.06728.x","article-title":"Fumaric acid esters for severe psoriasis: a retrospective review of 58 cases","volume":"153","author":"Harries","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14500-BIB0104|bjd14500-cit-0104","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1046\/j.1365-2133.2003.05424.x","article-title":"Efficacy of fumaric acid ester monotherapy in psoriasis pustulosa palmoplantaris","volume":"149","author":"St\u00e4nder","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14500-BIB0105|bjd14500-cit-0105","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/000155501317208408","article-title":"Addition of pentoxifylline could reduce the side effects of fumaric acid esters in the treatment of psoriasis","volume":"81","author":"Friedrich","year":"2001","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/bjd.14500-BIB0106|bjd14500-cit-0106","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1365-2133.1998.02124.x","article-title":"Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study","volume":"138","author":"Mrowietz","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14500-BIB0107|bjd14500-cit-0107","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000017903","article-title":"Fumaric acid esters suppress peripheral CD4- and CD8-positive lymphocytes in psoriasis","volume":"196","author":"H\u00f6xtermann","year":"1998","journal-title":"Dermatology"},{"key":"10.1111\/bjd.14500-BIB0108|bjd14500-cit-0108","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s001050050401","article-title":"Efficacy and safety profile of fumaric acid esters in oral long-term therapy of severe psoriasis vulgaris. An investigation of 83 patients","volume":"47","author":"Altmeyer","year":"1996","journal-title":"Hautarzt"},{"key":"10.1111\/bjd.14500-BIB0109|bjd14500-cit-0109","first-page":"272","article-title":"Long term observations of lymphocyte subsets in psoriatic patients treated with fumaric acid esters","volume":"22","author":"Altmeyer","year":"1996","journal-title":"Aktuel Dermatol"},{"key":"10.1111\/bjd.14500-BIB0110|bjd14500-cit-0110","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1055\/s-2008-1065114","article-title":"Acute renal failure during treatment of psoriasis with fumaric acid derivatives","volume":"115","author":"Dalhoff","year":"1990","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1111\/bjd.14500-BIB0111|bjd14500-cit-0111","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1055\/s-2008-1065215","article-title":"Nephrotoxic effects of fumaric acid ester during treatment of psoriasis","volume":"115","author":"St\u00fchlinger","year":"1990","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1111\/bjd.14500-BIB0112|bjd14500-cit-0112","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1365-2230.2011.04047.x","article-title":"Proteinuria with fumaric acid ester treatment for psoriasis","volume":"36","author":"Ogilvie","year":"2011","journal-title":"Clin Exp Dermatol"},{"issue":"Suppl. 1","key":"10.1111\/bjd.14500-BIB0113|bjd14500-cit-0113","first-page":"PC08\/32","article-title":"Kaposi-sarcoma during therapy with fumaric acid esters","volume":"39","author":"Philipp","year":"2009","journal-title":"Eur J Immunol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.14500","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.14500","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.14500\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T09:19:27Z","timestamp":1676366367000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/175\/2\/250\/6616515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,19]]},"references-count":113,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,8]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.14500","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726177887.793515187","asserted-by":"object"}]},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7,19]]}}}